← Back to Patent Explorer
US4246344A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of detecting adherent cells

Assignee: 3M Co
•
Filing: 1979-04-09
•
Granted: 1981-01-20
•
Expires: 1999-04-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method is disclosed for the direct quantitative measurement of adherent cells in a liquid sample. The method consists of contacting and incubating the sample with a piezoelectric oscillator having a premeasured resonant frequency, washing and drying the oscillator and determining its change in frequency.

Inventors

  • 👤 Spencer F. Silver, III

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 08:37
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/5005; G01N33/5094

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 76 words
A method for the direct quantitative measurement of adherent cells in a liquid sample comprising the steps of: a. contacting said liquid sample with the surface of a piezoelectric oscillator having a premeasured resonant frequency; b. incubating said sample and said oscillator for a sufficient period of time to allow said cells to contact said surface; c. washing and drying said oscillators; and d. determining the change in frequency of said oscillator from said premeasured frequency.
Claim 2
Independent Claim 76 words
A method for the direct quantitative measurement of adherent cells in a liquid sample comprising the steps of: a. contacting said liquid sample with the surface of a piezoelectric oscillator having a premeasured resonant frequency; b. incubating said sample and said oscillator for a sufficient period of time to allow said cells to contact said surface; c. washing and drying said oscillators; and d. determining the change in frequency of said oscillator from said premeasured frequency.
Claim 3
Dependent Claim 13 words
The method according to claim 1 wherein said oscillator is a quartz crystal.
Claim 4
Dependent Claim 15 words
The method according to claim 1 wherein said cells are leukocytes derived from peripheral blood.
Claim 5
Dependent Claim 20 words
The method according to claim 3 wherein said leukocytes are selected from the group consisting of granulocytes and mononuclear cells.
Claim 6
Dependent Claim 29 words
The method according to claim 1 wherein said cells are derived from a source selected from the group consisting of lymph nodes and fluid, thymus, spleen and peritoneal exudate.
Claim 7
Dependent Claim 11 words
The method according to claim 1 wherein said cells are fibroblasts.
Claim 8
Dependent Claim 21 words
The method according to claim 1 further comprising the step of pretreating said oscillator with autologous serum prior to step a.
Claim 9
Dependent Claim 22 words
The method according to claim 1 further comprising the step of adding autologous serum to said liquid sample prior to step a.
Claim 10
Dependent Claim 14 words
The method according to claim 1 wherein said liquid sample contains fetal calf serum.
Claim 11
Dependent Claim 23 words
The method according to claim 1 wherein said oscillator has a layer of a positively charged material applied thereto prior to step a.
Claim 12
Dependent Claim 13 words
The method according to claim 10 wherein said positively charged material is poly(2-hydroxy-3-dimethylamino-1,4-butane).
Claim 13
Dependent Claim 23 words
The method according to claim 1 wherein said oscillator has a layer of a negatively charged material applied thereto prior to step a.
Claim 14
Dependent Claim 14 words
The method according to claim 12 wherein said negatively charged material is gum arabic.
Claim 15
Dependent Claim 20 words
The method according to claim 1 wherein said oscillator has a layer of polystyrene applied thereto prior to step a.
Claim 16
Dependent Claim 21 words
The method according to claim 1 wherein said oscillator has a layer of an antigen applied thereto prior to step a.
Claim 17
Dependent Claim 44 words
The method according to claim 15 wherein said antigen is selected from the group consisting of viral antigens, parasitic antigens, fungal antigens, tumor antigens, antigenic products of viruses, antigenic products of parasites, antigenic products of fungi, antigenic products of tumors, and plant derived lectins.
Claim 18
Dependent Claim 23 words
The method according to claim 15 wherein said antigen is selected from the group consisting of contact dermatitis antigens and autoimmune disease-associated antigens.
Claim 19
Dependent Claim 13 words
The method according to claim 15 wherein said antigen is a microbial antigen.
Claim 20
Independent Claim 115 words
A method for the direct quantitative measure of chemotaxis comprising the steps of: a. placing at least one drop of liquid sample containing a chemotactic agent on the surface of a piezoelectric oscillator having a premeasured resonant frequency; b. covering said drop with a porous membrane; c. placing at least one drop of a liquid sample containing cells over said membrane; d. allowing the product of steps a-c to incubate for a sufficient period of time to allow said cells to migrate through said membrane to surface of said oscillator; e. removing said porous membrane; f. washing and drying said oscillator; and g. determining the change in frequency of said oscillator from said premeasured frequency.
Claim 21
Independent Claim 115 words
A method for the direct quantitative measure of chemotaxis comprising the steps of: a. placing at least one drop of liquid sample containing a chemotactic agent on the surface of a piezoelectric oscillator having a premeasured resonant frequency; b. covering said drop with a porous membrane; c. placing at least one drop of a liquid sample containing cells over said membrane; d. allowing the product of steps a-c to incubate for a sufficient period of time to allow said cells to migrate through said membrane to surface of said oscillator; e. removing said porous membrane; f. washing and drying said oscillator; and g. determining the change in frequency of said oscillator from said premeasured frequency.
Claim 22
Dependent Claim 19 words
The method according to claim 19 wherein said cells used in step c are leukocytes derived from peripheral blood.
Claim 23
Dependent Claim 29 words
The method according to claim 19 wherein said cells are derived from a source selected from the group consisting of lymph nodes and fluid, thymus, spleen and peritoneal exudate.
Claim 24
Independent Claim 79 words
A method for the direct quantitative measurement of phagocytosis comprising to steps of: a. contacting a liquid sample containing cells and a predetermined number of particles with the surface of a piezoelectric oscillator having a premeasured resonant frequency; b. incubating said sample and said oscillator for a sufficient period of time to allow said cells to contact said surface; c. washing and drying said oscillators; and d. determining the change in frequency of said oscillator from said premeasured frequency.
Claim 25
Independent Claim 79 words
A method for the direct quantitative measurement of phagocytosis comprising to steps of: a. contacting a liquid sample containing cells and a predetermined number of particles with the surface of a piezoelectric oscillator having a premeasured resonant frequency; b. incubating said sample and said oscillator for a sufficient period of time to allow said cells to contact said surface; c. washing and drying said oscillators; and d. determining the change in frequency of said oscillator from said premeasured frequency.
Claim 26
Dependent Claim 13 words
The method according to claim 22 wherein said liquid sample contains autologous serum.
Claim 27
Dependent Claim 21 words
The method according to claim 22 wherein said particles are selected from the group consisting of zymosan starch and polystyrene latex.

References Cited (Backward Citations)

US3164004A Cited
US3329004A Cited
US3653253A Cited
US3715911A Cited
US3879992A Cited
US3856466A Cited
US3895912A Cited
US3999944A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-01-20 1984-07-21 1985-01-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-01-20 1988-07-21 1989-01-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-01-20 1992-07-21 1993-01-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag